Differentiating rheumatoid arthritis from other diseases
Rheumatoid arthritis Microchapters | |
Diagnosis | |
---|---|
Treatment | |
Case Studies | |
Differentiating rheumatoid arthritis from other diseases On the Web | |
American Roentgen Ray Society Images of Differentiating rheumatoid arthritis from other diseases | |
FDA on Differentiating rheumatoid arthritis from other diseases | |
CDC on Differentiating rheumatoid arthritis from other diseases | |
Differentiating rheumatoid arthritis from other diseases in the news | |
Blogs onDifferentiating rheumatoid arthritis from other diseases | |
Risk calculators and risk factors for Differentiating rheumatoid arthritis from other diseases | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]
Overview
Differentiating Rheumatoid arthritis from other Diseases
- Osteoarthritis (OA):
- Signs and symptoms of osteoarthritis are usually minimal and spares the wrist joint and the metacarpophalangeal joint. It typically affects the distal inter-phalangeal joint and frequently associated with Heberden's nodes.
- Joint stiffness is usually minimal in OA and lasts less than one hour. In contrast, joint stiffness is a very prominent symptom of RA and should last more than an hour for atleast 6 weeks in order to fulfill the criteria for diagnosis defined by The American College of Rheumatology.[1]
- Systemic lupus erythematosus (SLE):
- Symptoms specific to SLE like butterfly malar rash, Discoid lupus erythromatosus, photosensitivity, myositis, nephritis are not seen in RA.
- The C reactive protein levels are often normal or mildly elevated in SLE, whereas it is always elevated in RA. However, the erythrocyte sedimentation rate is found to be elevated in both.
- Septic arthritis
- Bacterial cause: Characterized by fever, chills, joint swelling and tenderness, demonstration of causative organism in the aspirated joint fluid by gram staining or microbial culture.
- Viral cause: rubella, parvovirus B19, hepatitis B virus, hepatitis C virus are the most common responsible etiologic agents. The syndrome is often self limiting, lasting for a few weeks, and rarely beyond 6 weeks. Serology can help identifying HBV, HCV, parvovirus B19. Anti-CCP antibody is more specific than Rheumatoid factor for establishing a diagnosis of RA, as Rheumatoid factor levels may be raised in HCV infection.
- Lyme Arthritis: It is characterized by intermittent, persistent or migratory pattern of arthritis, often involving large joints like knee, shoulder, ankle, elbow, wrist and temporomandibular joint in the decreasing order of incidence. Involvement of small joints of the hand is not common with Lyme disease. Diagnosis is made by serology. Other clues include residing in an endemic area, antecedent history of erythema chronicum migrans.
- Gout:
- Polymyalgia rheumatica:
- It often asymmetric, seen in those above 50 years of age, involves proximal muscles of shoulder and hip, and tends to have a milder course.
- Stiffness involves the axial muscles more often than the small joints of hand that predominates RA.
- They are typically seronegative or have only a mild elevation of Rheumatoid factor and respond dramatically to glucocorticoids.
- Paraneoplastic syndromes:
- Hypertrophic pulmonary osteoarthropathy]]: Characterized by clubbing of digits, joint pain (deep and nagging type) and periosteal reaction.
- Myelodysplastic syndrome: Patients with myelodysplastic syndrome often present with various autoimmune diseases including polyarthritis which could be confused with RA.[2]
- Other differentials:
Differential diagnosis
Arthritis Type | Clinical Features | Body Distribution | Key Signs | Laboratory Abnormalities | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
History of Psoriasis | Symmetric joint involvement | Asymmetric joint involvement | Enthesopathy | Dactylitis | Nail Dystrophy | Human immunodeficiency virus association | Upper extremity-hands | Lower extremity | Sacroiliac joints | Spine | Osteopenia | Joint Space | Ankylosis | Periostitis | Soft tissue swelling | ESR | Rheumatoid factor (RF) | HLA-B27 | |
Psoriatic arthritis | + | + | ++ | + | + | + | + | +++ (DIP/PIP) | +++ | ++ (Unilateral) | ++ | - | ++ (Widening) | ++ | +++ (Fluffy) | ++ | + | - | 30-75% |
Rheumatoid arthritis | - | ++ | + | - | - | - | - | +++ | +++ | + (Unilateral) | ++(Cervical) | +++ | +++ (Narrowing) | + | + (Linear) | +++ | +++ | +++ | 6-8% |
Ankylosing spondylitis | - | +++ | - | + | - | - | - | + | + | +++ (Bilateral) | +++ | +++ | ++ (Narrowing) | +++ | +++ (Fluffy) | + | +++ | - | 90% |
Reactive arthritis (Reiter's syndrome) | - | +++ | - | + | + | - | - | ++ | +++ | ++ (Unilateral) | + | + | + (Narrowing) | - | +++ (Fluffy) | ++ | ++ | - | 75% |
Key:+ : Infrequently present, ++ : Frequently present, +++ : Always present, - : Absent
Disease | Differentiating signs and symptoms | Diagnostic findings |
---|---|---|
Fibromyalgia |
|
|
Rheumatoid arthritis |
|
|
SLE |
|
|
Chronic fatigue syndrome | Fatigue plus 4 of the following symptoms:
|
|
Spondyloarthritis |
|
|
Polymyalgia rheumatica |
|
|
Osteoarthritis |
|
|
Hypothyroidism |
|
|
Myopathaies (polymyositis and dermatomyositis) |
|
|
Neuropathy |
|
Causes of
lung cavities |
Differentiating Features | Differentiating radiological findings | Diagnosis
confirmation |
---|---|---|---|
|
|
| |
|
|
|
|
|
|
| |
|
|
|
|
|
|
| |
|
|
| |
|
|
||
|
|
| |
|
|
|
Arthritis Type | Clinical Features | Body Distribution | Key Signs | Laboratory Abnormalities | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
History of Psoriasis | Symmetric joint involvement | Asymmetric joint involvement | Enthesopathy | Dactylitis | Nail Dystrophy | Human immunodeficiency virus association | Upper extremity-hands | Lower extremity | Sacroiliac joints | Spine | Osteopenia | Joint Space | Ankylosis | Periostitis | Soft tissue swelling | ESR | Rheumatoid factor (RF) | HLA-B27 | |
Psoriatic arthritis | + | + | ++ | + | + | + | + | +++ (DIP/PIP) | +++ | ++ (Unilateral) | ++ | - | ++ (Widening) | ++ | +++ (Fluffy) | ++ | + | - | 30-75% |
Rheumatoid arthritis | - | ++ | + | - | - | - | - | +++ | +++ | + (Unilateral) | ++(Cervical) | +++ | +++ (Narrowing) | + | + (Linear) | +++ | +++ | +++ | 6-8% |
Ankylosing spondylitis | - | +++ | - | + | - | - | - | + | + | +++ (Bilateral) | +++ | +++ | ++ (Narrowing) | +++ | +++ (Fluffy) | + | +++ | - | 90% |
Reactive arthritis (Reiter's syndrome) | - | +++ | - | + | + | - | - | ++ | +++ | ++ (Unilateral) | + | + | + (Narrowing) | - | +++ (Fluffy) | ++ | ++ | - | 75% |
Key:+ : Infrequently present, ++ : Frequently present, +++ : Always present, - : Absent
Disease | Differentiating signs and symptoms | Diagnostic findings |
---|---|---|
Fibromyalgia |
|
|
Rheumatoid arthritis |
|
|
SLE |
|
|
Chronic fatigue syndrome | Fatigue plus 4 of the following symptoms:
|
|
Spondyloarthritis |
|
|
Polymyalgia rheumatica |
|
|
Osteoarthritis |
|
|
Hypothyroidism |
|
|
Myopathaies (polymyositis and dermatomyositis) |
|
|
Neuropathy |
|
References
- ↑ Arnett FC, Edworthy SM, Bloch DA; et al. (1988). "The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis". Arthritis and Rheumatism. 31 (3): 315–24. PMID 3358796. Unknown parameter
|month=
ignored (help);|access-date=
requires|url=
(help) - ↑ Farmakis D, Polymeropoulos E, Polonifi A; et al. (2005). "Myelodysplastic syndrome associated with multiple autoimmune disorders". Clinical Rheumatology. 24 (4): 428–30. doi:10.1007/s10067-004-1059-4. PMID 15827686. Retrieved 2012-04-27. Unknown parameter
|month=
ignored (help) - ↑ 3.0 3.1 Chaudhuri MR (1973). "Primary pulmonary cavitating carcinomas". Thorax. 28 (3): 354–66. PMC 470041. PMID 4353362.
- ↑ Mouroux J, Padovani B, Elkaïm D, Richelme H (1996). "Should cavitated bronchopulmonary cancers be considered a separate entity?". Ann. Thorac. Surg. 61 (2): 530–2. doi:10.1016/0003-4975(95)00973-6. PMID 8572761.
- ↑ Onn A, Choe DH, Herbst RS, Correa AM, Munden RF, Truong MT, Vaporciyan AA, Isobe T, Gilcrease MZ, Marom EM (2005). "Tumor cavitation in stage I non-small cell lung cancer: epidermal growth factor receptor expression and prediction of poor outcome". Radiology. 237 (1): 342–7. doi:10.1148/radiol.2371041650. PMID 16183941.
- ↑ 6.0 6.1 Langford CA, Hoffman GS (1999). "Rare diseases.3: Wegener's granulomatosis". Thorax. 54 (7): 629–37. PMC 1745525. PMID 10377211.
- ↑ Lee KS, Kim TS, Fujimoto K, Moriya H, Watanabe H, Tateishi U, Ashizawa K, Johkoh T, Kim EA, Kwon OJ (2003). "Thoracic manifestation of Wegener's granulomatosis: CT findings in 30 patients". Eur Radiol. 13 (1): 43–51. doi:10.1007/s00330-002-1422-2. PMID 12541109.
- ↑ Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H, Bresnitz EA, DePalo L, Hunninghake G, Iannuzzi MC, Johns CJ, McLennan G, Moller DR, Newman LS, Rabin DL, Rose C, Rybicki B, Weinberger SE, Terrin ML, Knatterud GL, Cherniak R (2001). "Clinical characteristics of patients in a case control study of sarcoidosis". Am. J. Respir. Crit. Care Med. 164 (10 Pt 1): 1885–9. doi:10.1164/ajrccm.164.10.2104046. PMID 11734441.
- ↑ Brauner MW, Grenier P, Mompoint D, Lenoir S, de Crémoux H (1989). "Pulmonary sarcoidosis: evaluation with high-resolution CT". Radiology. 172 (2): 467–71. doi:10.1148/radiology.172.2.2748828. PMID 2748828.
- ↑ Murphy J, Schnyder P, Herold C, Flower C (1998). "Bronchiolitis obliterans organising pneumonia simulating bronchial carcinoma". Eur Radiol. 8 (7): 1165–9. doi:10.1007/s003300050527. PMID 9724431.
- ↑ 11.0 11.1 Al-Ghanem S, Al-Jahdali H, Bamefleh H, Khan AN (2008). "Bronchiolitis obliterans organizing pneumonia: pathogenesis, clinical features, imaging and therapy review". Ann Thorac Med. 3 (2): 67–75. doi:10.4103/1817-1737.39641. PMC 2700454. PMID 19561910.
- ↑ Cordier JF, Loire R, Brune J (1989). "Idiopathic bronchiolitis obliterans organizing pneumonia. Definition of characteristic clinical profiles in a series of 16 patients". Chest. 96 (5): 999–1004. PMID 2805873.
- ↑ Lee KS, Kullnig P, Hartman TE, Müller NL (1994). "Cryptogenic organizing pneumonia: CT findings in 43 patients". AJR Am J Roentgenol. 162 (3): 543–6. doi:10.2214/ajr.162.3.8109493. PMID 8109493.
- ↑ Suri HS, Yi ES, Nowakowski GS, Vassallo R (2012). "Pulmonary langerhans cell histiocytosis". Orphanet J Rare Dis. 7: 16. doi:10.1186/1750-1172-7-16. PMC 3342091. PMID 22429393.
- ↑ Moore AD, Godwin JD, Müller NL, Naidich DP, Hammar SP, Buschman DL, Takasugi JE, de Carvalho CR (1989). "Pulmonary histiocytosis X: comparison of radiographic and CT findings". Radiology. 172 (1): 249–54. doi:10.1148/radiology.172.1.2787035. PMID 2787035.